<DOC>
	<DOCNO>NCT02148471</DOCNO>
	<brief_summary>The first aim study assess oxidative stress nutritional status patient elevate liver enzymes find either simple steatosis ( SS ) nonalcoholic steatohepatitis ( NASH ) normal histological finding liver biopsy measure liver lipid peroxide tumor necrosis factor ( TNF ) -α , liver pathology immunohistochemistry , liver function test , liver red blood cell membrane fatty composition , insulin resistance ( IR ) parameter , plasma lipid peroxide , plasma antioxidant vitamins antioxidant power , lipid profile , subject demographic , medical history medication use . The second aim detect difference hepatic gene expression ( messenger RNA , mRNA ) epigenetic regulation ( micro RNA , miRNA ) patient SS NASH healthy control , addition determine patient non-alcoholic fatty liver disease ( NAFLD = SS+NASH combine ) whether association hepatic n-3 PUFA content gene expression . The third aim determine intestinal microbiome ( microbial composition metagenome ) patient SS NASH healthy control .</brief_summary>
	<brief_title>Fatty Acids , Genes Microbiota Fatty Liver</brief_title>
	<detailed_description>NASH associate obesity , diabetes hyperlipidemia . Fat accumulation liver likely due variable degree disorder fatty-acid metabolism insulin resistance ( IR ) . Liver steatosis , especially polyunsaturated fatty acid ( PUFA ) liver , increase lipid peroxidation associate reduction antioxidant defense system . This oxidative stress lead increase production pro-inflammatory cytokine ( TNF-α , transform growth factor-beta ) contributing development steatohepatitis fibrosis.TNF-α - may contribute IR . In addition , change fatty acid composition within liver may influence lipid metabolism inflammation . In particular , n-3 PUFA effect insulin sensitivity , transcription antioxidant gene , inflammatory response production reactive oxygen specie . Differences might see gene expression level ( mRNA ) also epigenetic regulation ( miRNA ) . Microbiota composition might influence energy metabolism , inflammatory tone IR increase endotoxemia therefore could also play role development NAFLD .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Inclusion criterion : Male female patient , age &gt; 18 A liver biopsy diagnosis SS NASH OR No sign steatosis , fibrosis kind liver disease histology ( minimal finding ) OR For healthy control subject , normal liver enzymes normal liver image ultrasound alcohol consumption ( &lt; 20g ethanol per day ) ; absence possible cause liver dysfunction . Exclusion criterion : liver disease apart NAFLD anticipate need liver transplantation one year complication liver disease ; reason contraindicate liver biopsy ( patient ) liver donation ( healthy donor ) chronic gastrointestinal disease , previous gastrointestinal surgery modify anatomy , patient diabetes require insulin . medication know precipitate steatohepatitis ( corticosteroid , high dose estrogen , methotrexate , amiodarone , spironolactone , sulfasalazine , perhexiline maleate , diethylamino ethoxyhexestrol ( DH ) , tamoxifen , diethylstilbestrol , naproxen oxacillin ) regular intake nonsteroidal antiinflammatory drug ( except low dose aspirin ) , use ursodeoxycholic acid experimental drug 6 month prior entry . regular intake prebiotics , probiotic , antibiotic , laxative ; 3 month prior study entry Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Nonalcoholic fatty liver disease</keyword>
	<keyword>Steatosis</keyword>
	<keyword>Nonalcoholic steatohepatitis</keyword>
</DOC>